Examkin

Soru

Zorluk: Çok zorSubstance-Related and Addictive Disorders

A 54-year-old man is admitted to the hospital with acute pancreatitis. He has a 15-year history of heavy daily alcohol consumption, and his last drink was 24 hours ago. On examination, he is agitated, diaphoretic, and tremulous. Vital signs show a temperature of 37.8°C (100.0°F), blood pressure of 165/95 mm Hg, and heart rate of 118/min. Laboratory studies reveal a blood glucose of 68 mg/dL, aspartate aminotransferase (AST) of 185 U/L, alanine aminotransferase (ALT) of 82 U/L, and total bilirubin of 3.2 mg/dL. He has temporal muscle wasting and a scaphoid abdomen. The patient expresses a strong desire to achieve long-term sobriety after this hospitalization. Arrange the following steps in the most appropriate chronological order for the comprehensive management of this patient, from immediate acute stabilization to long-term relapse prevention.

  1. 1Immediate intravenous administration of a water-soluble vitamin cofactor essential for alpha-ketoglutarate dehydrogenase, prior to dextrose infusion.
  2. 2Symptom-triggered administration of a short-acting GABA-A receptor modulator that undergoes hepatic metabolism solely via glucuronidation.
  3. 3Continuous clinical monitoring using a validated scale until complete resolution of autonomic hyperactivity and agitation.
  4. 4Initiation of an oral NMDA-receptor antagonist to maintain abstinence, selected specifically due to the patient's compromised hepatic function.

Cevap

The correct sequence begins with acute nutritional stabilization (thiamine before glucose), followed by acute withdrawal management (lorazepam due to hepatic impairment), clinical observation until resolution of acute symptoms, and finally the initiation of long-term maintenance therapy (acamprosate).
The management of severe alcohol use disorder progresses sequentially from immediate stabilization of life-threatening deficiencies to acute withdrawal management, followed by long-term relapse prevention. Thiamine must precede glucose to prevent Wernicke encephalopathy. Benzodiazepines managed via glucuronidation (lorazepam, oxazepam, temazepam) are used for withdrawal to prevent hepatic accumulation. After withdrawal resolves, acamprosate is the preferred maintenance drug due to the patient's underlying liver dysfunction, which contraindicates naltrexone.

Adım Adım Çözüm

1
Analyze the patient's immediate nutritional and metabolic needs.
The patient has hypoglycemia and signs of severe malnutrition, requiring immediate dextrose. However, thiamine must be given first.
Administering glucose without prior thiamine administration can deplete the remaining thiamine stores, precipitating Wernicke encephalopathy.
2
Determine the appropriate pharmacological management for the acute withdrawal symptoms.
The patient is experiencing acute alcohol withdrawal and has evidence of alcoholic hepatitis (AST:ALT ratio > 2, elevated bilirubin).
Lorazepam is preferred because it relies exclusively on glucuronidation (Phase II metabolism) and does not accumulate in patients with hepatic impairment, unlike long-acting agents such as chlordiazepoxide or diazepam.
3
Identify the necessary transition criteria from acute detoxification to chronic management.
The patient must be closely monitored until acute autonomic symptoms and agitation completely resolve.
Long-term maintenance therapy is most effective and safe when initiated after the acute detoxification phase has concluded.
4
Select the most appropriate long-term pharmacotherapy for relapse prevention.
Acamprosate is selected as the maintenance agent upon preparation for discharge.
Naltrexone is contraindicated in patients with severe hepatic impairment or acute hepatitis. Acamprosate is renally excreted and is safe for this patient.

Anahtar Kavram

Chronological Management of Severe Alcohol Use Disorder with Hepatic Impairment
Bu soruyu puanla

Konular

Substance-Related and Addictive Disorders

Bu konudan daha fazla soru